Theme: Hope Grows Here fight Back Endocrine Cancer

Neuroendocrine Tumors (NETs) 2016

Neuroendocrine Tumors (NETs) 2016

Global Congress on Neuroendocrine Tumors: Radiation Medicine and Therapies. International Conferences invites all the participants from all over the world to attend the prestigious Scientific Conference on  Endocrine Disorders and Radiation Medicine  during November,7-9, 2016 in Las Vegas, USA which includes prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions.

Neuroendocrine Tumors 2016 (NETs) is a global platform to discuss and learn about early detection as well as treatment, care based on expert standards, and increased research to achieve cure for all Neuroendocrine cancer.  The conference includes leading international experts in Neuroendocrine cancer and Radiation Medicine hospitals specialists, doctors, research scholars and general practitioners form all over the world.

About neuroendocrine tumors: Neuroendocrine tumors are abnormal growths that begin in specialized cells called neuroendocrine cells, which are traditional hormone-producing endocrine cells and nerve cells. Neuroendocrine cells are found throughout the body in organs such as the lungs and gastrointestinal tract, including the stomach and intestines. These hormones perform specific functions, such as regulating the air and blood flow through the lungs and controlling the speed at which food is moved through the gastrointestinal tract.

Track 1: Cancer

Cancer, also called malignancy, is an abnormal growth of cells. There are more than 100 types of cancer, including breast cancer, skin cancer, lung cancer, colon cancer, prostate cancer, and lymphoma. Symptoms vary depending on the type. Cancer treatment may include chemotherapy, radiation, and/or surgery

Recommended Conferences  Cancer ConferencesCancer MeetingsCancer Events 

Cancer Diagnostics Conference & Expo June 13-15, 2016 Rome, Italy; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; European Radiology Congress July 14-15, 2016 Cologne, Germany; International Conference on Radiography November 17-18, 2016 Dubai, UAE; Advances in Medical and Surgical Management of Thyroid Cancer January 15-16, 2016; Middle East Thyroid Cancer Conference, May 24-26, 2016 Dubai, UAE; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA; AACE Diagnostic Endocrine Neck Ultrasound and UGFNA Course May 23-24, 2016, Orlando, USA

 

Track 2: Neuroendocrine Tumors Pathophysiology

The pathophysiology of Neuroendocrine Cancer is not completely defined. Neuroendocrine tumors are rare and can occur anywhere in the body. Most neuroendocrine tumors occur in the lungs, appendix, small intestine, rectum and pancreas. Neuroendocrine tumors can be noncancerous (benign) or cancerous (malignant). Examples of Neuroendocrine tumors are they include Carcinoid tumors,(they are mainly confined to intestinal tract, thymus or lungs), Medullary thyroid Carcinoma, Merkel cell Carcinoma, pheochromocytoma, Adrenal Cancer, small cell Carcinoma and large cell Carcinoma.

Recommended Conferences  Cancer ConferencesCancer MeetingsCancer Events        

International Conference on Oral, Mouth and Throat Cancer August 18-20, 2016 Portland, USA; 2nd International Conference on Prostate Cancer and Treatment May 05-07, 2016 Chicago, USA; 6th International Conference on Endocrinology November 28-30, 2016 Baltimore, USA; International Conference on Thyroid Disorders and Treatment February 29-March 02, 2016 Philadelphia, USA; 2nd Global Summit on Hormones and Steroids June 23-25, 2016 New Orleans, USA; 19th International Thyroid Cancer Survivors' Conference October 2-4, 2016 St. Louis, USA; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE; The Endocrine Society Annual Meeting April 1-4, 2016 Boston, USA; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA; 39th Annual Meeting of the European Thyroid Association (ETA) September 3-7, 2016 Copenhagen, Denmark

Track 3: Neuroendocrine Tumors: Causes

Nneuroendocrine tumors (NET) characteristically grow slowly. Approximately half of all patients never develop hormone related symptoms and syndromes. NET producing excessive amounts of hormones and biogenic amines are also called functional or hormone-active tumors whereas non-“hyper secretory” tumors are correspondingly referred to as non-functional or hormone-inactive NET. In the latter case, as a consequence most patients have widespread disease at first diagnosis. While the overall incidence of gastroenteropancreatic (GEP) NET in postmortem examinations is 2/100,000, the clinical incidence of GEP NET is only 0.3-0.7/100,000. Accordingly, pancreatic NET have even a 2-fold lower incidence, i.e. 0.2-0.03/100,000. Neuroendocrine pancreatic tumors derive from the so-called foregut. Their natural course is considerably worse as compared to midgut tumors . Pancreatic NET are characterized by a local spread infiltrating adjacent nerve fibers, vessels and lymph nodes. In addition, metastases are primarily observed in the liver and at later stages in the bone, orbita, mediastinum and lungs.

Recommended Conferences  Cancer ConferencesCancer MeetingsCancer Events                     

International Conference on Oral, Mouth and Throat Cancer August 18-20, 2016 Portland, USA; 2nd International Conference on Prostate Cancer and Treatment May 05-07, 2016 Chicago, USA; 6th International Conference on Endocrinology November 28-30, 2016 Baltimore, USA; International Conference on Thyroid Disorders and Treatment February 29-March 02, 2016 Philadelphia, USA; 2nd Global Summit on Hormones and Steroids June 23-25, 2016 New Orleans, USA; The Endocrine Society Annual Meeting April 1-4, 2016 Boston, USA; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA; 39th Annual Meeting of the European Thyroid Association (ETA) September 3-7, 2016 Copenhagen, Denmark; 19th International Thyroid Cancer Survivors' Conference October 2-4, 2016 St. Louis, USA; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE

Track 4: Neuroendocrine Tumors: Types 

Cancers arise from cells that have undergone a change (malignant transformation) and begin to abnormally divide and multiply. Tumour associated inflammation may be slow or progress rapidly and invade or spread into other tissues. There are many types of neuroendocrine tumors such as pituitary gland, pineal gland, thyroid gland, parathyroid and adrenal glands a types of cancer that begin in hormone-producing cells among them three specific types: pheochromocytoma, Merkel cell cancer, and neuroendocrine carcinoma. 

Recommended Conferences  Cancer ConferencesCancer MeetingsCancer Events                     

International Conference on Oral, Mouth and Throat Cancer August 18-20, 2016 Portland, USA; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 10th Global Annual Oncologists Meeting July 11-13, 2016 Cologne, Germany; 12th Global Summit on Cancer Therapy September 26-28, 2016 London, UK; 13th Global Summit on Cancer Therapy October 17-19, 2016 Dubai, UAE; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE; AACE Diagnostic Endocrine Neck Ultrasound and UGFNA Course May 23 - 24, 2016, Orlando, USA; Advances in Medical and Surgical Management of Thyroid Cancer January 15-16, 2016; 19th International Thyroid Cancer Survivors' Conference October 2-4, 2016 St. Louis, USA; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA

Track 5: Staging of Neuroendocrine Tumors

Staging is the process of finding out if and how far a cancer has spread. The stage of a cancer is one of the most important factors in choosing treatment options and predicting your chance for cure. Staging is based on the results of the physical exam, biopsy research, and imaging tests (ultrasound, radioiodine scan, TSH test, MRI, chest x-ray, and/or PET scans). A staging system is a standard way to sum up how large a cancer is and how far it has spread. The most common system used to describe the stages of Neuroendocrine cancer is Physical exam and history , Blood chemistry studies, Chromogranin A test: Abdominal CT scan (CAT scan), MRI(magnetic resonance imaging), Somatostatin receptor Scintigraphy, Endoscopic ultra sound (EUS), Endoscopic retrograde cholangiopancreatography (ERCP), Angiogram, Laporotomy, Intraoperative ultrasound, Biopsy, Bone Scan, Other kinds of lab tests are performed to check for the specific type of NET’s.

 Recommended Conferences  Cancer ConferencesCancer MeetingsCancer Events                                 

6th World Congress on Cancer Therapy December 01-03, 2016 Baltimore, USA; Cancer Diagnostics Conference & Expo June 13-15, 2016 Rome, Italy; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; International Conference and Expo on Molecular & Cancer Biomarkers September 15-17, 2016 Berlin, Germany; International Conference on Leukemia and Bone marrow Transplantation November 10-12, 2016 Istanbul, Turkey; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE; AACE Diagnostic Endocrine Neck Ultrasound and UGFNA Course May 23 - 24, 2016, Orlando, USA; Advances in Medical and Surgical Management of Thyroid Cancer January 15-16, 2016; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA; 39th Annual Meeting of the European Thyroid Association (ETA) September 3-7, 2016 Copenhagen, Denmark

Track 6: Diagnosis of Neuroendocrine Tumors

There are many tests to diagnose cancer and find out if it has spread to another part of the body, called metastasis. Some tests may also determine the treatments which may be the most effective. For most types of cancer, a biopsy research is the only way to make a definitive diagnosis of cancer. If a biopsy is not possible, the doctor may suggest other tests that will help make a diagnosis. Diagnostic Imaging may be used to find out whether the cancer has spread. Factors like Age and medical condition, type of cancer suspected, Signs and symptoms and previous test results are important for choosing a diagnostic test.

Recommended Conferences  Cancer ConferencesCancer MeetingsCancer Events                           

Cancer Diagnostics Conference & Expo June 13-15, 2016 Rome, Italy; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; International Conference and Expo on Molecular & Cancer Biomarkers September 15-17, 2016 Berlin, Germany; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 10th Global Annual Oncologists Meeting July 11-13, 2016 Cologne, Germany; The Endocrine Society Annual Meeting April 1-4, 2016 Boston, USA; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA; 39th Annual Meeting of the European Thyroid Association (ETA) September 3-7, 2016 Copenhagen, Denmark; 19th International Thyroid Cancer Survivors' Conference October 2-4, 2016 St. Louis, USA; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE

Track 7: Neuroendocrine  Tumors Research and Treatment

Working is going on about Neuroendocrine Cancer, ways to prevent it, how to best treat it, and how to provide the best care to people diagnosed with this disease. Evidence has grown showing the benefits of combining Oncoplastic Surgery with radioactive iodine therapy and Specific hormone therapy. The results include higher cure rates, lower recurrence rates, and longer survival. Understanding the abnormal gene sequencing that cause sporadic (not inherited) Neuroendocrine cancer has led to better treatments. Most Neuroendocrine cancers can be treated successfully. But advanced cancers can be hard to treat, especially if they do not respond to radioactive iodine (RAI) therapy. Surgery is an effective treatment for most Neuroendocrine cancers.

Recommended Conferences  Cancer ConferencesCancer MeetingsCancer Events                               

Cancer Diagnostics Conference & Expo June 13-15, 2016 Rome, Italy; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; 4th Global Radiologists Annual Meeting March 17-18, 2016 London, UK; 5th International Conference on Radiology and Imaging September 19-20, 2016 Las Vegas, USA; European Radiology Congress July 14-15, 2016 Cologne, Germany; International Conference on Radiography November 17-18, 2016 Dubai, UAE; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE; AACE Diagnostic Endocrine Neck Ultrasound and UGFNA Course May 23 - 24, 2016, Orlando, USA; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA; 39th Annual Meeting of the European Thyroid Association (ETA) September 3-7, 2016 Copenhagen, Denmark

Track 8: Surgery for Neuroendocrine Tumors 

Surgery is the main treatment in nearly every case of Neuroendocrine cancer, except for some parts of cancers. If Neuroendocrine cancer is diagnosed by  biopsy, surgery to remove the tumor and all or part of the remaining tumor cells is recommended. The advantage of surgery if it can be done, is that some patients might not need to take  hormone pills afterward because it leaves part of the gland behind. But having some gland left can interfere with some tests that look for cancer recurrence after treatment, such as radioiodine scans and blood tests.

Recommended Conferences  Cancer ConferencesCancer MeetingsCancerEvents   

Global Radiologists Annual Meeting March 17-18, 2016 London, UK; 5th International Conference on Radiology and Imaging September 19-20, 2016 Las Vegas, USA; European Radiology Congress July 14-15, 2016 Cologne, Germany; International Conference on Radiography November 17-18, 2016 Dubai, UAE; International Conference and Exhibition on Surgical Oncology September 01-03, 2016 Sao Paulo, Brazil; 19th International Thyroid Cancer Survivors' Conference October 2-4, 2016 St. Louis, USA; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE; The Endocrine Society Annual Meeting April 1-4, 2016 Boston, USA; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA

Track 9: Neuroendocrine Tumors Prevention 

Genetic blood tests can be used to identify people who have a high risk of developing the familial types Cancer. When inherited on strikes one family member, all family members can be tested. Those who test positive but have no symptoms of cancer may decide to have their treatmentin advance to prevent the disease. After surgery, these patients need to take specific hormones basing on the gland that is removed to maintain the metabolic activities of the body for the rest of their lives.

Recommended Conferences  Cancer ConferencesCancer MeetingsCancer Events

5th International Conference on Radiology and Imaging September 19-20, 2016 Las Vegas, USA; European Radiology Congress July 14-15, 2016 Cologne, Germany; International Conference on Radiography November 17-18, 2016 Dubai, UAE; Cancer Diagnostics Conference & Expo June 13-15, 2016 Rome, Italy; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; 4th Global Radiologists Annual Meeting March 17-18, 2016 London, UK; The Endocrine Society Annual Meeting April 1-4, 2016 Boston, USA; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA; 39th Annual Meeting of the European Thyroid Association (ETA) September 3-7, 2016 Copenhagen, Denmark; 19th International Thyroid Cancer Survivors' Conference October 2-4, 2016 St. Louis, USA; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE

Track 10: Neuroendocrine Tumors Trends and Opportunities

Neuroendocrine Market: Trends and Opportunities provide an insight into the overall Endocrine cancer market of the United States of America. The report analyzes in detail the segments of Neuroendocrine Cancer Diagnostics Surgeries, Neuroendocrine Histopathology Market, Endocrine Cancer Secondary Surgery and Endocrine Cancer Hormone Replacement Market.

Recommended Conferences  Cancer ConferencesCancer MeetingsCancer Events 

European Radiology Congress July 14-15, 2016 Cologne, Germany; International Conference on Radiography November 17-18, 2016 Dubai, UAE; Cancer Diagnostics Conference & Expo June 13-15, 2016 Rome, Italy; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA; 39th Annual Meeting of the European Thyroid Association (ETA) September 3-7, 2016 Copenhagen, Denmark; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE; AACE Diagnostic Endocrine Neck Ultrasound and UGFNA Course May 23 - 24, 2016, Orlando, USA

Track 11: External Radiation Medicine

Radiation Medicine is a  process in wich they use high-energy radiation, in the form of waves or particles, to destroy cancer cells by damaging their DNA. Because radiation can harm healthy cells, treatment must be carefully planned and precisely conducted to minimize side effects. Radiation therapy may be given before, during, or after other therapies in your treatment plan. It may be used alone or with other treatments to destroy cancer cells, shrink tumors, prevent recurrence and relieve symptoms caused by the cancer, such as pain. The Radiation team plans the treatment by choosing the type, dose and area of radiation therapy to be performed. Radiation therapies include different delivery External radiation.

 Recommended Conferences  Cancer ConferencesCancer MeetingsCancer Events      

6th World Congress on Cancer Therapy December 01-03, 2016 Baltimore, USA; Cancer Diagnostics Conference & Expo June 13-15, 2016 Rome, Italy; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; International Conference and Expo on Molecular & Cancer Biomarkers September 15-17, 2016 Berlin, Germany; International Conference on Leukemia and Bone marrow Transplantation November 10-12, 2016 Istanbul, Turkey; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE; AACE Diagnostic Endocrine Neck Ultrasound and UGFNA Course May 23 - 24, 2016, Orlando, USA; Advances in Medical and Surgical Management of Thyroid Cancer January 15-16, 2016; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA; 39th Annual Meeting of the European Thyroid Association (ETA) September 3-7, 2016 Copenhagen, Denmark

Track 12: Internal Radiation Medicine           

Radiation Medicine is a process in wich they use high-energy radiation, in the form of waves or particles, to destroy cancer cells by damaging their DNA. Because radiation can harm healthy cells, treatment must be carefully planned and precisely conducted to minimize side effects. Radiation therapy may be given before, during, or after other therapies in your treatment plan. It may be used alone or with other treatments to destroy cancer cells, shrink tumors, prevent recurrence and relieve symptoms caused by the cancer, such as pain. The Radiation team plans the treatment by choosing the type, dose and area of radiation therapy to be performed. Internal radiation(these include different radioactive material like seeds, beads, wires or other radioactive substances for the treatment by placing them within the body near the cancer cells. People involved in radiation medicine are Medical Physicist, Radiation Oncologist, Dosimetrist, Radiation Therapist

Recommended Conferences  Cancer ConferencesCancer MeetingsCancer Events  

5th International Conference on Radiology and Imaging September 19-20, 2016 Las Vegas, USA; European Radiology Congress July 14-15, 2016 Cologne, Germany; International Conference on Radiography November 17-18, 2016 Dubai, UAE; Cancer Diagnostics Conference & Expo June 13-15, 2016 Rome, Italy; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; 4th Global Radiologists Annual Meeting March 17-18, 2016 London, UK; The Endocrine Society Annual Meeting April 1-4, 2016 Boston, USA; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA; 39th Annual Meeting of the European Thyroid Association (ETA) September 3-7, 2016 Copenhagen, Denmark; 19th International Thyroid Cancer Survivors' Conference October 2-4, 2016 St. Louis, USA; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE

Track 13: Nuclear Medicine

Nuclear medicine imaging uses small amounts of radioactive materials called radiotracers that are typically injected into the blood stream, inhaled or swallowed. The radiotracer travels through the area being examined and gives off energy in the form of gamma rays which are detected by a special camera and a computer to create images of the inside of your body. Nuclear medicine imaging provides unique information that often cannot be obtained using other imaging procedures and offers the potential to identify disease in its earliest stages.

Recommended Conferences  Cancer ConferencesCancer MeetingsCancer Events 

Cancer Diagnostics Conference & Expo June 13-15, 2016 Rome, Italy; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; 4th Global Radiologists Annual Meeting March 17-18, 2016 London, UK; 5th International Conference on Radiology and Imaging September 19-20, 2016 Las Vegas, USA; European Radiology Congress July 14-15, 2016 Cologne, Germany; International Conference on Radiography November 17-18, 2016 Dubai, UAE; Middle East Thyroid Cancer Conference, May 24 - 26, 2016 Dubai, UAE; AACE Diagnostic Endocrine Neck Ultrasound and UGFNA Course May 23 - 24, 2016, Orlando, USA; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA; 39th Annual Meeting of the European Thyroid Association (ETA) September 3-7, 2016 Copenhagen, Denmark

Track 14: Neuroendocrine Tumors Market

Neuroendocrine Cancer has received considerable R&D attention over the past two decades but very few drugs have been approved. Although NET’s and thyroid cancer have low incidence, the significant unmet needs for effective treatment for patients with advanced tumor associated inflammation makes them attractive to drug developers. The 15 drugs in late-stage development forecast in this report are expected to achieve sales of $957m by 2019. Several drugs in the latephase pipeline are set to impact the three markets, including PLX-4032 and Ipilimumab in melanoma, Nexavar in thyroid cancer, and Afinitor in neuroendocrine tumors.

 Recommended Conferences  Cancer ConferencesCancer MeetingsCancer Events                          

Cancer Diagnostics Conference & Expo June 13-15, 2016 Rome, Italy; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; European Radiology Congress July 14-15, 2016 Cologne, Germany; International Conference on Radiography November 17-18, 2016 Dubai, UAE; Advances in Medical and Surgical Management of Thyroid Cancer January 15-16, 2016; Middle East Thyroid Cancer Conference, May 24-26, 2016 Dubai, UAE; AHNS 9th International Conference on Head and Neck Cancer July 16-20, 2016 Seattle, USA; AACE Diagnostic Endocrine Neck Ultrasound and UGFNA Course May 23-24, 2016, Orlando, USA

 

Global Congress on Neuroendocrine Tumors: Radiation Medicine and Therapies. International Conferences invites all the participants from all over the world to attend the prestigious Scientific Conference on  Endocrine Disorders and Radiation Medicine  during November,7-9, 2016 in Las Vegas, USA which includes prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions.

Neuroendocrine Tumors 2016  provide a platform for the multidisciplinary discussion on research, education, and patient management of Endocrine malignancy. We summarize the latest major trends and controversies within the field of Neuroendocrine oncology and Radiation Practices  including the use of ultrasound, standardization of cytology, role of molecular testing, treatment options for small recurrence including ablation and observation, management of recurrent laryngeal nerve injury, importance of identification of the external branch of the superior laryngeal nerve, role of minimally invasive Neuroendocrine surgery, trends in radioactive iodine treatment, advancements in targeted agents, and the importance of personalizing treatment to individual patients.

 

conference Series LLC organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Why to attend???

With members from around the world focused on learning about Neuroendocrine Tumors and its advances; this is your best opportunity to reach the largest assemblage of participants from the Endocrine Tumors community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Neuroendocrine Tumors are hallmarks of this conference.

Target Audience:

  • Neuroendocrine and Radiation Tumors Students, Scientists
  •  Neuroendocrine and Radiation Tumors Researchers
  • Neuroendocrine and Radiation Tumors Faculty
  • Medical Colleges
  • Neuroendocrine and Radiation Associations and Societies
  • Training Institutes
  • Manufacturing Medical Devices Companies

Neuroendocrine Tumors Market: Drivers and Restraints

Significant increase in funding for treatment of cancer by various international organizations such as American Cancer Academy and world Health Organization is expected to boost overall neuroendocrine carcinoma treatment market. Furthermore, significant increase in healthcare spending along with high prevalence rate of neuroendocrine carcinoma in developing region is expected to boost overall neuroendocrine carcinoma market.  Though market is expected to witness healthy growth, lack of skilled healthcare professional and lower adoption of advanced treatment technologies in the developing economies are key restrains for neuroendocrine carcinoma market.

Neuroendocrine Carcinoma Market: Segmentation

Neuroendocrine Carcinoma market further segmented into many types basing on the following factors. a) By Treatment this covers (surgery, Medication, Anti-metabolite, Platinum-derivatives, Topoisomerase inhibitor, Anthracycline antibiotic) b) By End User (Hospital, Clinics, Drug store, Pharmacies)

Neuroendocrine Carcinoma Market: Overview

Neuroendocrine tumors (NETs) are malignant tumors that originate in endocrine cells and targets digestive tract that misbalances hormonal release. The market is expected to witness healthy CAGR during the forecast period.

Neuroendocrine Carcinoma Market: Region- wise Outlook

The global Neuroendocrine Carcinoma Market is expected to register a impressive CAGR over the forecast period. Depending on geographic regions, global neuroendocrine carcinoma market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa  

North America dominates the global neuroendocrine carcinoma market owing to presence of modern healthcare amenities along with significant healthcare expenditure in these regions. Europe occupies second place in this market with its new regulations in the major economies. Asia also shows a healthy growth rate in this market.

Neuroendocrine Carcinoma Market: Key Players

Some of the key players in this market include

  Novartis AG, F. Hoffman La Roche, Callisto Pharmaceuticals,Eli Lilly &      Company,Ipsen,,Molecular Insight Pharmaceuticals, Amgen Inc.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

 

 

The report covers exhaustive analysis on:

·         Market Segments

·         Market Dynamics

·         Market Size

·         Supply & Demand

·         Current Trends/Issues/Challenges

·         Competition & Companies involved

·         Technology

·         Value Chain

Regional analysis includes:

North America (U.S., Canada), Latin America (Mexico. Brazil), Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg), Eastern Europe (Poland, Russia), Asia Pacific (China, India, ASEAN, Australia & New Zealand), Japan, Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

·         Detailed overview of parent market

·         Changing market dynamics in the industry

·         In-depth market segmentation

·         Historical, current and projected market size in terms of volume and value

·         Recent industry trends and developments

·         Competitive landscape

·         Strategies of key players and products offered

·         Potential and niche segments, geographical regions exhibiting promising growth

·         A neutral perspective on market performance

·         Must-have information for market players to sustain and enhance their market footprint

 

Cancer Summit 2015

OMICS Group’s 5th Asia-Pacific Summit on Cancer Therapy at Park Regis Brisbane, Australia during July 20-22, 2015 was organized with a focus on "Forum for a world without cancer was a great success where eminent keynote speakers from various reputed institutions made their resplendent presence and addressed the gathering.

Cancer Summit-2015 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various newfangled topics related to the field of cancer.

Cancer Summit-2015 Organizing Committee would like to thank the Moderator of the conference, Dr. Rupinder Kaur Kanwar, Deakin University, K who contributed a lot for the smooth functioning of this event.

OMICS Group International would like to convey a warm gratitude to all the Honorable guests and Keynote Speakers of Cancer Summit-2015:

Jagat R Kanwar, Deakin University, Australia

Kwok-nam Leung, The Chinese University of Hong Kong, Hong Kong

Izhak Haviv, Bar Ilan University, Israel

Pascal H G Dujif, University of Queensland, Australia

Veronica J James, Australian National University, Australia

OMICS Group, on behalf of the conference, congratulates the Best Poster awardees for their outstanding performance and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors. We would like to thank the Poster Competition Judge Dr. Izhak Haviv, Bar Ilan University, Israel for his valuable time.

Best Poster Winners:


OMICS Group also took the privilege of felicitating Cancer Summit-2015 Organizing Committee, Editorial Board Members of Journals of Cancer Science & Therapy, Journal of Carcinogenesis & Mutagenesis and Journal of Integrative Oncology, Keynote Speakers, Chair and Co-Chairs and Moderator whose support made conference a great success.

With the enormous feedback from the participants and supporters of Cancer Summit-2015, OMICS Group Conferences is glad to announce

11th Asia-Pacific Oncologists Summit


Past Reports  Gallery  

Chemotherapy-2015

Over thousands of scholars from the field of Chemotherapy stepped away from their nations last Tuesday, August 2nd, 2015to take part in an ostentatious event “International Conference on Antimicrobial Agents and Chemotherapy” August 04-06, 2015, in Valencia, Spain. The conference was organized around a single theme “Emerging techniques and advancements in the field of chemotherapy which comprised of 06 tracks with knowledge oriented presentations igniting young minds in the crowd.

The Conference provided a rostrum for interaction among keynotes, chair & co-chairs, plenary speakers, poster presentees, young research fellows & delegates and to share their experiences, ideas & research, thus helping to generate a new way of looking at Cancer treatments.

Conference began with the welcome message given by our moderator Dr. Emil Toma, University of Montreal, USA, followed by a Keynote series of well-known speakers:

  • Dr. Emil Toma, University of Montreal, USA.
  • Dr. Didier Coquoz, Copexis, Switzerland.
  • Dr. Hiroyuki Osada, RIKEN Center for Sustainable Resource Science, Japan.

The session was chaired by Dr. Emil Toma, University of Montreal, USA, preceded with paramount Oral Presentations. The Conference also witnessed an amalgamation of eminent speakers like:

  • Junjun Qiu, Obstetrics and Gynecology Hospital of Fudan University, China.
  • Helene Castel, Universite de Rouen, France
  • Paula Sabbo Bernado, Brazilian National Cancer Institute, Brazil.

The Conference also provided a platform for a grandiose Workshop by:

  • Isabel Portero Sanchez, Universidad Complutense & BIOHOPE Scientific Solutions, Spain
  • Dirk Buscher, Gri-Cel S.A. Spain
  • Eva Martin Becerra, Gradocell& IMMPULSO Medical Sciences, Spain

The second day session was chaired and Keynote speech was given by:

  • Dr. Hiroyuki Osada, RIKEN Center for Sustainable Resource Science, Japan

The session was preceded by Oral Presentations by:

  • Dr. Hiroyuki Osada, RIKEN Center for Sustainable Resource Science, Japan
  • Dr. Minoru Yoshida, RIKEN Center for Sustainable Resource Science, Japan
  • Natalia Martins, Polytechnic Institute of Braganca, Portugal

A Global Platform was given to students to explore their research work under the category Young Research Forum:

  • Bin Li, University of Hong Kong, China
  • Wen WenXu, University of Hong Kong, China
  • Natalia Martins, Polytechnic Institute of Braganca, Portugal
  • Maude Loignon, University of Montreal, Canada

OMICS International acknowledges all the Organizing Committee Members, Moderator, Chair and Editorial Board Members of OMICS group Journals, Speakers, Students, Delegates and Media Partners in making this event a great success. We are also obliged to various government authorities, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members, for their gracious presence, support and assistance.

After the immense and grand response received from Chemotherapy-2015, OMICS International proudly announces the 2nd International Conference on Antimicrobial Agents and Chemotherapy


Past Reports  Gallery  

Cancer Science-2014

OMICS Group’s 4th World Congress on Cancer Science & Therapy was held during October 20-22, 2014 at DoubleTree by Hilton Hotel Chicago - North Shore Conference Center, Chicago, USA.

Generous response and active participation was received from the Editorial Board Members of OMICS Group Journals, scientists, researchers, as well as experts in the cancer research, leaders from the fields of Cancer Therapy, and students from diverse groups, who made this conference one of the most successful and productive events in 2014 from OMICS Group.

The conference proceedings were carried out through effectual keynote lectures by:

Dr. Peter Weightman, University of Liverpool, UK
Dr. Sudhakar Akul Yakkanti, SRI International, USA
Dr. Jeffrey B. Ulmer, Novartis Vaccines & Diagnostics, USA
Dr. Reza Hakkak, University of Arkansas for Medical Sciences, USA

This annual conference brought together eminent experts from different countries in which many modern issues were discussed in depth to provide up-to-date information to the world. On the other hand, the meeting provided a good platform to share their ideas and experiences in the field of cancer therapy.

The conference was greeted by the welcome message by our moderators Juan Jose Marugan, National Institutes of Health, USA and Bernard Friedenson, University of Illinois, USA, and welcomed Honorable guests Sudhakar Akul Yakkanti, SRI International, USA, Anupam Bishayee, California Northstate University, USA, and Reza Hakkak, University of Arkansas for Medical Sciences, USA.

We sincerely acknowledge all the organizing committee members, moderators, chair and co-chairs, editorial board members, speakers, delegates for their gracious presence, and support in making this event successful. OMICS Group has taken the privilege of felicitating Cancer Science-2014 Organizing Committee Members, Editorial Board Members and Keynote Speakers who supported for the success of this event. OMICS Group, on behalf of the conference exhibitors congratulates the Best Poster awardees for their outstanding performance in the field of Cancer Science & Therapy and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Cancer Science-2014. We are glad to inform that all accepted abstracts for the conference have been indexed in OMICS Group Journal of Cancer Science & Therapy and Journal of Carcinogenesis & Mutagenesis as a special issue. Basing on the conference theme, "Enhanced diagnosis, treatment and management of different cancers”, the speakers recommended organizing the conference in the field of Cancer Science and Therapy in the coming years also.

We are obliged to various experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance towards the success of Cancer Science-2014.


Past Reports  Gallery  

Cancer Science-2013

The 3rd World Congress on Cancer Science & Therapy was organized by OMICS Group Inc., during October 21-23, 2013 at Double Tree by Hilton Hotel San Francisco Airport, USA. Active participation and generous response was received from the Organizing Committee Members, Editorial Board Members of OMICS Group Journals, scientists, researchers, as well as experts in the cancer research, Non-government organizations, and students from diverse groups who made this conference as one of the most successful and productive events in 2013 from OMICS Group.

The conference was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who have driven this event into the path of success.

The conference was initiated with a warm welcome note from Honorable guests. The proceedings went through interactive sessions and panel discussions headed by Jimmy T. Efird, Brody School of Medicine, USA; honorable Moderator for the conference.

The conference proceedings were carried out through various Keynote-presentations by:

  • Dr. Stewart Sell, Wadsworth Center, USA
  • Dr. Michael Retsky, Harvard School of Public Health, USA
  • Dr. Jimmy T. Efird, Brody School of Medicine, USA
  • Dr. Sudhakar Akul Yakkanti, SRI International, USA
  • Dr. Sherry A. Bradford, Buffalo School of Medical and Biomedical Sciences, USA

Also, the conference proceeding was encouraged through the wonderful workshop session on “ Animal Models of Cancer Therapy” organized by Dr. Dorothee Herlyn, The Wistar Institute, USA

OMICS Group has taken the privilege of felicitating Cancer Science-2013 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event. OMICS Group, on behalf of the conference exhibitors congratulates the Best Poster awardees for their outstanding performance in the field of Cancer Science & Therapy and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Cancer Science-2013. We are glad to inform that all accepted abstracts for the conference have been indexed in OMICS Group Journal of Cancer Science & Therapy and Journal of Carcinogenesis & Mutagenesis as a special issue. Basing on the conference theme, "Innovations and Novel Therapeutic Strategies in Cancer Science speakers recommended organizing the conference in the field of Cancer Science and Therapy also in the next year.

We are also obliged to various experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance towards the success of Cancer Science-2013.


Past Reports  Gallery  

Radiology-2013

OMICS Group organized an International Conference on Radiology and Imaging which was held during August 14-16, 2013 in Holiday Inn Chicago Northshore, USA. The congress was organized with the goal of providing a platform for the future development of the discipline. Generous response and active participation was received from the Editorial Board Members of OMICS Group Journals as well as from scientists, researchers and NIH, students who made this conference as one of the most successful events in 2013 from OMICS Group.

The conference was carried out through the following sessions:

  • Acquisition of Radiological Images
  • Interventional Radiology Procedures
  • Applications of Radiography
  • Disorders of Interventional Radiology
  • Radiation Therapy
  • Radiology for the Non-Radiologist
  • Advances in Imaging
  • Diagnostic Imaging Techniques
  • Radiopharmaceuticals
  • PET/MRI versus PET/CT Hybrid

 

The main theme of this Conference was "An Insight into Advanced Methodologies in Radiology".

The conference was initiated with a series of invited lectures delivered by both Honorable Guests and members of the Keynote forum.

Keynote speakers:

  • Ravinder Reddy, University of Pennsylvania, USA
  • Hollis Potter, Hospital for Special Surgery, USA
  • Xiaohong Zhou, University of Illinois, USA

Some of the eminent speeches were given by:

  • Jiang Du, University of California, USA
  • Michael L. Goris, Stanford University School of Medicine, USA
  • Hua Guo, Tsinghua University School of Medicine, China
  • Morio Sato, Wakayama Medical University, Japan
  • Shuo li, GE Healthcare, Canada

Dr. David Cheng, Yale University, USA, acted as a moderator and helped in making this conference a huge success.

All accepted abstracts have been indexed in OMICS Journal of Radiology as a special issue.


Past Reports  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date November 07-09, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Conferenceseries Destinations